CT

Catch up on the most well-read computed tomography (CT) articles from 2022.

In a recently published prospective study comparing photon-counting detector computed tomography (PCD CT) versus energy-integrating detector CT (EID CT) in patients with persistent symptoms after COVID-19 infection, researchers found that PCD CT discovered additional lung abnormalities in half of the study participants.

Catch up on the top AI-related news and research of the past month.

Check out the top radiology content of the past week.

Employing an artificial intelligence (AI) tool to quantify airway-to-artery (AAR) diameter ratios on chest computed tomography (CT), researchers found the percentage of airways with an AAR greater than 1 was associated with increased pulmonary exacerbations in ever-smokers.

Review the case study and test your knowledge to make the correct diagnosis.

Relief from looming reimbursement cuts, a PACS system that allows customized keyboard shortcuts and consistently relevant clinical histories are a few of the items on the wish list for this radiologist.

Catch up on the top radiology content of the past week.

In a new study based on five- to six-year follow-up data from over 650,000 children and young adults who had at least one computed tomography (CT) exam prior to the age of 22, researchers found a “strong dose-response relationship” between increased CT radiation exposure and brain cancer.

Review the case study and test your knowledge to make the correct diagnosis.

Lamenting the deteriorating quality of clinical histories that radiologists receive from referring clinicians, this author comically speculates about clinical histories one may see in the near future.

Main pulmonary artery and right ventricular diameters on computed tomography (CT) scans of the thorax were predictors of pulmonary hypertension.

Ultra-low-dose computed tomography (ULDCT) may have similar efficacy as low-dose CT (LDCT) for detecting a variety of pulmonary conditions in people with current or past smoking histories, but had poor detection of ground glass opacification lesions, according to a recent prospective study presented at the Radiological Society of North America (RSNA) conference.

Enhancements for the BodyTom 64 Point-of-Care Mobile Computed Tomography (CT) Scanner include upgraded cross-sectional imaging capabilities and a Linux operating system.

Offering more than 70 clinical applications, the next-generation edition of the Advanced Visualization Workspace reportedly includes enhanced liver analysis and artificial intelligence (AI)-powered scoring of early brain infarction noted on computed tomography (CT) scans for patients with ischemic stroke.

New research suggests the Viz Aortic Dissection Algorithm has a 94.2 percent sensitivity rate for detecting aortic dissection on computed tomography (CT) angiography.

Emphasizing the benefits of annual lung cancer screening with low-dose computed tomography (CT), researchers noted high 20-year survival rates for a variety of early-stage lung cancer tumor presentations, including a 100 percent survival rate for those with non-solid or partly solid cancerous nodules.

Building a career for the long haul requires a foundation of good life and work habits as well as an openness to innovation and change.

Catch up on the top radiology content of the past week.

GE Healthcare’s DaTscan is reportedly the first radiopharmaceutical tracer agent approved by the Food and Drug Administration (FDA) for use in patients with suspected dementia with Lewy bodies.

A new computed tomography study reveals that people who smoke marijuana may have a 70 percent higher risk of developing emphysema than non-smokers, and an age-matched subgroup analysis suggests marijuana use could be associated with a 26 percent higher risk of emphysema in comparison to tobacco-only smoking.

The ebbs and flows of worklists in radiology require equal parts productivity and preservation.

Catch up on the top radiology content of the past week.

A new study of nearly 17 million emergency department (ED) visits by Medicare beneficiaries between 2005 and 2020 revealed the presence of non-physician practitioners (NPPs) was associated with a 5.3 percent increase in imaging.

Findings from a recent multinational phase III trial demonstrated that the investigational agent TLX250-CDx had an 86 percent sensitivity rate for detecting clear cell renal cell carcinoma via positron emission tomography/computed tomography (PET/CT).